$AGIO Headlines Four signs that would indicate a new

New Post Public Reply Private Reply Replies (0) Message Board

Jan 18, 2015 at 10:50 AM

$AGIO Headlines

Four signs that would indicate a new uptrend 2:52 p.m. Dec. 16, 2014 - The Trading Deck
Is the next Cisco out there? 3:24 p.m. Nov. 25, 2014 - The Trading Deck
Growth stocks provide litmus test for stock market 3:13 p.m. Nov. 18, 2014 - The Trading Deck
The double-edged sword of growth-stock speculation 2:30 p.m. Nov. 14, 2014 - The Trading Deck
Two biotech leaders to watch 1:13 p.m. Oct. 28, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
S&P 500 returns to scene of the breakdown 9:56 a.m. Oct. 3, 2014 - Michael Ashbaugh
15 small-cap stocks Goldman Sachs says are worth a look 10:51 a.m. July 22, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 8:20 a.m. April 7, 2014 - Sara Sjolin
Agios shares rally 6.4% premarket after upbeat trial results 6:28 a.m. April 7, 2014 - Sara Sjolin

A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week 1:00 a.m. Jan. 13, 2015 - Zacks.com
Value Investing Strategy For Biotech 12:57 p.m. Jan. 12, 2015 - Seeking Alpha
New Lifetime High Reached: Agios Pharmaceuticals (AGIO) 9:45 a.m. Jan. 12, 2015 - TheStreet.com
Why Agios Pharmaceuticals (AGIO) Could Be Positioned for a Surge? - Tale of the Tape 8:35 a.m. Jan. 12, 2015 - Zacks.com
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab 2:56 p.m. Jan. 9, 2015 - TheStreet.com
InsiderInsights.com Daily Round Up 1/6/15: XOMA, CODI, MNST, BBY 10:37 a.m. Jan. 8, 2015 - Seeking Alpha
Health-Care Stocks Avoid Malaise 8:34 p.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains 8:25 p.m. Jan. 6, 2015 - TheStreet.com
Public Shame for Biotechs Not Webcasting 'JPM15' Breakout Sessions 3:08 p.m. Jan. 6, 2015 - TheStreet.com
Jim Cramer: Why Are You Shorting Innovative Biotech Stocks? 11:37 a.m. Jan. 6, 2015 - TheStreet.com
Biotech Stocks 2014: The Best, Worst and Fastest-Growing 8:33 a.m. Jan. 2, 2015 - TheStreet.com
Bull of the Day: Incyte (INCY) - Bull of the Day 1:00 a.m. Jan. 2, 2015 - Zacks.com
Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens 6:00 a.m. Dec. 29, 2014 - TheStreet.com
Trade-Ideas: Agios Pharmaceuticals (AGIO) Is Today's "Dead Cat Bounce" Stock 9:57 a.m. Dec. 24, 2014 - TheStreet.com
Agios Pharmaceuticals (AGIO) in Focus: Stock Tanks 13.6% - Tale of the Tape 8:48 a.m. Dec. 24, 2014 - Zacks.com
Agios Pharmaceuticals (AGIO) Is Today's Water-Logged And Getting Wetter Stock 12:33 p.m. Dec. 23, 2014 - TheStreet.com
Seattle Genetics And Agios Pharmaceuticals: Opportunity Or Danger? 11:21 a.m. Dec. 23, 2014 - Seeking Alpha
3 Stocks With Plunging Prices 11:00 a.m. Dec. 23, 2014 - InvestorPlace.com
InsiderInsights.com Daily Round Up 12/18/14: Agios Pharmaceuticals, Inc.,Unit Corporation, China Cord Blood Corporation, Saba Software, Inc. 10:49 a.m. Dec. 19, 2014 - Seeking Alpha
Insider Trading Alert - USCR, AGIO And CVV Traded By Insiders 10:06 a.m. Dec. 19, 2014 - TheStreet.com

Agios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic Collaboration 9:24 p.m. Jan. 12, 2015 - GlobeNewswire
Biotechs to Follow in 2015 off Fresh Insider Moves 10:01 a.m. Jan. 6, 2015 - ACCESSWIRE
Agios Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12 4:06 p.m. Jan. 5, 2015 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Halliburton, Agios Pharmaceuticals and Urban Outfitters Released By InvestorsObserver 9:31 a.m. Dec. 16, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock 8:42 p.m. Dec. 10, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Proposed Offering of Common Stock 4:23 p.m. Dec. 9, 2014 - GlobeNewswire
Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors 4:02 p.m. Dec. 9, 2014 - GlobeNewswire
Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency 1:01 p.m. Dec. 8, 2014 - GlobeNewswire
Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016 7:31 a.m. Dec. 8, 2014 - GlobeNewswire
Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies 12:31 p.m. Dec. 7, 2014 - GlobeNewswire
Critical Alerts For Agios Pharmaceuticals, Target, Dollar General, Lululemon and Costco Released By InvestorsObserver 9:31 a.m. Nov. 20, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML) 6:01 p.m. Nov. 18, 2014 - GlobeNewswire
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results 7:01 a.m. Nov. 7, 2014 - GlobeNewswire
Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting 9:09 a.m. Nov. 6, 2014 - GlobeNewswire
Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Nov. 3, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014 7:32 a.m. Oct. 27, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation 7:31 a.m. Oct. 21, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221 6:30 a.m. Oct. 15, 2014 - GlobeNewswire
Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014 8:02 a.m. Oct. 6, 2014 - GlobeNewswire
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 7:55 a.m. Oct. 1, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Spooky Dining at CARNE: A Halloween Hit in Oxnard

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...